Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
In heavily pretreated patients with HER2-positive metastatic breast cancer, including those with brain metastases, adding tucatinib to trastuzumab and capecitabine resulted in b...